16 research outputs found
Hydrotreatment of the carbohydrate-rich fraction of pyrolysis liquids using bimetallic Ni based catalyst:Catalyst activity and product property relations
The use of novel nickel based catalysts for the catalytic hydrotreatment of pyrolytic sugars, the carbohydrate rich fraction of pine derived pyrolysis liquids, is reported. The catalysts are characterized by a high nickel loading (38 to 57 wt%), promoted by Cu, Pd, and/or Mo and a SiO2 based inorganic matrix. Experiments were carried out at 180 degrees C and 120 bar initial hydrogen pressure (room temperature) in a batch reactor set-up to gain insight in catalyst activity and product properties as a function of the catalyst composition. The most promising catalyst in terms of activity, as measured by the hydrogen uptake during reaction, was the Ni-Mo/SiO2-Al2O3 catalyst whereas the performance of the monometallic Ni/SiO2-Al2O3 catalyst was the lowest. As a result, the product oil obtained by the bimetallic Ni-Mo catalyst showed the highest H/C ratio and the lowest molecular weight of all catalysts tested. A detailed catalyst characterization study revealed that addition of Mo to the Ni catalyst suppresses the agglomeration of nickel nanoparticles during the catalytic hydrotreatment reaction
Unaccounted uncertainty from qPCR efficiency estimates entails uncontrolled false positive rates
MicroRNA signatures in B-cell lymphomas
Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the potential relevance of microRNA (miRNA) expression in a large series that included all major B-cell non-Hodgkin lymphoma (NHL) types. The data generated were also used to identify miRNAs differentially expressed in Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) samples. A series of 147 NHL samples and 15 controls were hybridized on a human miRNA one-color platform containing probes for 470 human miRNAs. Each lymphoma type was compared against the entire set of NHLs. BL was also directly compared with DLBCL, and 43 preselected miRNAs were analyzed in a new series of routinely processed samples of 28 BLs and 43 DLBCLs using quantitative reverse transcription-polymerase chain reaction. A signature of 128 miRNAs enabled the characterization of lymphoma neoplasms, reflecting the lymphoma type, cell of origin and/or discrete oncogene alterations. Comparative analysis of BL and DLBCL yielded 19 differentially expressed miRNAs, which were confirmed in a second confirmation series of 71 paraffin-embedded samples. The set of differentially expressed miRNAs found here expands the range of potential diagnostic markers for lymphoma diagnosis, especially when differential diagnosis of BL and DLBCL is required
X-ray Absorption Spectroscopic Studies of the Copper(I) Complexes of Crown Ether Appended Bis{(2-pyridyl)ethyl}amines and Their Dioxygen Adducts
Inflammation and vascular remodeling in COVID-19 hearts
A wide range of cardiac symptoms have been observed in COVID-19 patients, often significantly influencing the clinical outcome. While the pathophysiology of pulmonary COVID-19 manifestation has been substantially unraveled, the underlying pathomechanisms of cardiac involvement in COVID-19 are largely unknown. In this multicentre study, we performed a comprehensive analysis of heart samples from 24 autopsies with confirmed SARS-CoV-2 infection and compared them to samples of age-matched Influenza H1N1 A (nā=ā16), lymphocytic non-influenza myocarditis cases (nā=ā8), and non-inflamed heart tissue (nā=ā9). We employed conventional histopathology, multiplexed immunohistochemistry (MPX), microvascular corrosion casting, scanning electron microscopy, X-ray phase-contrast tomography using synchrotron radiation, and direct multiplexed measurements of gene expression, to assess morphological and molecular changes holistically. Based on histopathology, none of the COVID-19 samples fulfilled the established diagnostic criteria of viral myocarditis. However, quantification via MPX showed a significant increase in perivascular CD11b/TIE2ā+āāmacrophages in COVID-19 over time, which was not observed in influenza or non-SARS-CoV-2 viral myocarditis patients. Ultrastructurally, a significant increase in intussusceptive angiogenesis as well as multifocal thrombi, inapparent in conventional morphological analysis, could be demonstrated. In line with this, on a molecular level, COVID-19 hearts displayed a distinct expression pattern of genes primarily coding for factors involved in angiogenesis and epithelial-mesenchymal transition (EMT), changes not seen in any of the other patient groups. We conclude that cardiac involvement in COVID-19 is an angiocentric macrophage-driven inflammatory process, distinct from classical anti-viral inflammatory responses, and substantially underappreciated by conventional histopathologic analysis. For the first time, we have observed intussusceptive angiogenesis in cardiac tissue, which we previously identified as the linchpin of vascular remodeling in COVID-19 pneumonia, as a pathognomic sign in affected hearts. Moreover, we identified CD11bā+ā/TIE2ā+āmacrophages as the drivers of intussusceptive angiogenesis and set forward a putative model for the molecular regulation of vascular alterations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10456-022-09860-7